All Stories

  1. Development of a Deep Learning Algorithm for Posterior Fossa Abnormality Recognition on First-Trimester US Screening Scans: AIRFRAME Study Part 1
  2. Author Reply
  3. Authors' reply
  4. Author Reply
  5. Author response
  6. Effect of Targeted Aspirin Administration Based on First Trimester Combined Screening for Preeclampsia on Preterm Birth: An Interrupted Time Series Analysis
  7. Cardiac dysfunction during adverse maternal outcomes in hypertensive disorders of pregnancy
  8. ISUOG Consensus Statement on maternal hemodynamic assessment in hypertensive disorders of pregnancy and fetal growth restriction
  9. Impact of hypertensive disorders on disease progression in pregnancies affected by early‐onset fetal growth restriction
  10. Ambulatory foetal ECG monitoring in low and high-risk pregnancies (AMBER2): a prospective cohort study protocol
  11. Delphi consensus definition of fetal growth restriction after 8 years: implementation and future directions
  12. Translatable in‐vivo investigation of effects of progressive hypoxia in pregnancy on fetal cardiac structure and function in sheep
  13. Assessing the Clinical Effectiveness of the TRUFFLE Monitoring Protocol for Early-Onset Fetal Growth Restriction: a Retrospective Cohort Study.
  14. Foetal Cardiac Function in Early Labour and Intrapartum Outcomes: A Prospective Observational Study
  15. Predicting Adverse Perinatal Outcomes in Dichorionic Twin Pregnancies: A Multicentre Cohort Study
  16. The Impact of Dating Twin Pregnancy by the Larger, Smaller or Mean Twin Crown‐Rump Length: A Retrospective Cohort Study
  17. CARDIAC DYSFUNCTION DURING ADVERSE MATERNAL OUTCOMES IN HYPERTENSIVE DISORDERS OF PREGNANCY
  18. Comparison of glycosylated fibronectin versus soluble fms-like tyrosine kinase/placental growth factor ratio testing for the assessment of pre-eclampsia: protocol for a multicentre diagnostic test accuracy study
  19. Point‐of‐Care Tests for Preeclampsia: Systematic Review and Meta‐Analysis of Diagnostic Test Accuracy Studies
  20. Postnatal outcome of fetal cortical malformations: systematic review
  21. Cardiovascular Adaptation in Fetal Growth Restriction: A Longitudinal Study From Fetuses at Term to the First Year of Life
  22. TWIN PREGNANCY OUTCOMES WHEN DATING BY THE LARGER, SMALLER OR MEAN TWIN CROWN-RUMP LENGTH: A COHORT STUDY
  23. Maternal ethnicity and socioeconomic deprivation: influence on adverse pregnancy outcomes
  24. Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation
  25. Prenatal prediction of adverse outcome using different charts and definitions of fetal growth restriction
  26. Angiogenic markers and maternal echocardiographic indices in women with hypertensive disorders of pregnancy
  27. Routine first‐trimester pre‐eclampsia screening and maternal left ventricular geometry
  28. Postpartum cardiovascular function in patients with hypertensive disorders of pregnancy: a longitudinal study
  29. Pre-eclampsia and Cardiovascular Disease: From Pregnancy to Postpartum
  30. Correlation of short‐term variation derived from novel ambulatory fetal electrocardiography monitor with computerized cardiotocography
  31. Phase‐rectified signal averaging: correlation between two monitors and relationship with short‐term variation of fetal heart rate
  32. The significance of meeting Dawes–Redman criteria in computerised antenatal fetal heart rate assessment
  33. Is mid‐gestational uterine artery Doppler still useful in a setting with routine first‐trimester pre‐eclampsia screening? A cohort study
  34. Pan-Genomic Regulation of Gene Expression in Normal and Pathological Human Placentas
  35. Peripartum and Long-Term Maternal Cardiovascular Health After Preeclampsia
  36. Authors' reply re: The dangers of biological essentialism in addressing birth equity
  37. Routine first‐trimester pre‐eclampsia screening and risk of preterm birth
  38. Placental dysfunction screening and perinatal loss
  39. Pregnant women having a small for gestational age fetus present lower cardiac contractility
  40. Maternal echocardiographic changes in twin pregnancies with and without pre‐eclampsia
  41. Understanding maternal postnatal blood pressure changes following hypertensive disorders in pregnancy: protocol for a prospective cohort study
  42. Reducing health inequality in Black, Asian and other minority ethnic pregnant women: impact of first trimester combined screening for placental dysfunction on perinatal mortality
  43. Peripartum echocardiographic changes in women with hypertensive disorders of pregnancy
  44. Myocardial Mechanics in Hypertensive Disorders of Pregnancy: a Systematic Review and Meta-Analysis
  45. SARS-CoV-2 related myocardial injury might explain the predisposition to preeclampsia with maternal SARS-CoV-2 infection
  46. The placenta and preeclampsia: villain or victim?
  47. Effect of routine first‐trimester combined screening for pre‐eclampsia on small‐for‐gestational‐age birth: secondary interrupted time series analysis
  48. Re: ASPRE trial: risk factors for development of preterm pre‐eclampsia despite aspirin prophylaxis
  49. Placenta Accreta Spectrum Disorders and Cesarean Scar Pregnancy Screening: Are we Asking the Right Questions?
  50. Urgent neonatal balloon atrial septostomy in simple transposition of the great arteries: predictive value of fetal cardiac parameters
  51. Preeclampsia: Universal Screening or Universal Prevention for Low and Middle-Income Settings?
  52. The association between a shared placenta and pregnancy outcome in triplet pregnancies
  53. Time to reconsider elective Cesarean birth
  54. Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low‐lying placenta and previous uterine surgery
  55. Incidence of postpartum hypertension within 2 years of a pregnancy complicated by pre‐eclampsia: a systematic review and meta‐analysis
  56. Reduction in twin stillbirth following implementation of NICE guidance
  57. Performance of Antenatal Diagnostic Criteria of Twin-Anemia-Polycythemia Sequence
  58. Non‐immune fetal hydrops: etiology and outcome according to gestational age at diagnosis
  59. The Association Between Hypertension in Pregnancy and Preterm Birth with Fetal Growth Restriction in Singleton and Twin Pregnancy: Use of Twin Versus Singleton Charts
  60. Maternal Cardiac Dysfunction Precedes Development of Preeclampsia
  61. Implementation of routine first trimester combined screening for pre‐eclampsia: a clinical effectiveness study
  62. Post-Laser Twin Anemia Polycythemia Sequence: Diagnosis, Management, and Outcome in an International Cohort of 164 Cases
  63. Selective Fetal Growth Restriction in Dichorionic Twin Pregnancies: Diagnosis, Natural History, and Perinatal Outcome
  64. Speckle Tracking Echocardiography: New Ways of Translational Approaches in Preeclampsia to Detect Cardiovascular Dysfunction
  65. Evidence for uteroplacental malperfusion in fetuses with major congenital heart defects
  66. Role of prenatal magnetic resonance imaging in fetuses with isolated mild or moderate ventriculomegaly in the era of neurosonography: a multicenter study
  67. Diagnosis of fetal abnormalities using exome sequencing: translating research into practice
  68. Cesarean Scar Pregnancy Registry: an international research platform
  69. Ductus venosus Doppler waveform pattern in fetuses with early growth restriction
  70. The impact of gestational diabetes on maternal cardiac adaptation to pregnancy
  71. Maternal cardiovascular function and risk of intrapartum fetal compromise in women undergoing induction of labor: a pilot study
  72. Maternal arterial stiffness in hypertensive pregnancies with and without a small‐for‐gestational‐age neonate
  73. Consensus diagnostic criteria and monitoring of twin anemia polycythemia sequence: a Delphi procedure
  74. Influence of maternal characteristics and gestational age on hemodynamic indices: NICOM device‐specific reference ranges
  75. Cardiac maladaptation in obese pregnant women at term
  76. Early and late selective fetal growth restriction in monochorionic diamniotic twin pregnancies: natural history and diagnostic criteria
  77. Are maternal hemodynamic indices markers of fetal growth restriction in pregnancies with a small‐for‐gestational‐age fetus?
  78. Preeclampsia: The Relationship between Uterine Artery Blood Flow and Trophoblast Function
  79. Impact of ethnicity on adverse perinatal outcome in women with chronic hypertension: a cohort study
  80. Weight discordance and perinatal mortality in monoamniotic twin pregnancies: analysis of the MONOMONO, NorSTAMP and STORK multiple pregnancy cohorts
  81. Comparative analysis of the 2‐year outcomes in the GRIT and TRUFFLE trials
  82. Left ventricular torsional mechanics in term fetuses and neonates
  83. Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics
  84. Long‐term neuroimaging and neurological outcome of fetal spina bifida aperta after postnatal surgical repair
  85. Prediction of adverse pregnancy outcome in monochorionic diamniotic twin pregnancy complicated by selective fetal growth restriction
  86. Risk of operative delivery for intrapartum fetal compromise in small-for-gestational-age fetuses at term: external validation of the IRIS algorithm
  87. Perinatal outcome of monochorionic twin pregnancy complicated by selective fetal growth restriction according to management: systematic review and meta‐analysis
  88. Selective fetal growth restriction in monochorionic twin pregnancy: a dilemma for clinicians and a challenge for researchers
  89. Longitudinal change in the cerebroplacental ratio and the risk of stillbirth
  90. Maternal and perinatal outcomes after elective induction of labor at 39 weeks in uncomplicated singleton pregnancy: a meta‐analysis
  91. Perinatal changes in fetal cardiac geometry and function in gestational diabetic pregnancies at term
  92. Preeclampsia and the cardiovascular system: An update
  93. Placental thickness in the lower uterine segment and invasive placentation: Will the promise live up?
  94. Cardiac output measurements during high-risk caesarean section using electrical bioreactance or arterial wave form analysis: an assessment of agreement
  95. Lower uterine segment placental thickness in women with abnormally invasive placenta
  96. Book: Genetics for obstetricians and gynaecologists
  97. Sensitivity of first-trimester ultrasound in the detection of congenital anomalies in twin pregnancies: population study and systematic review
  98. Mid-pregnancy fetal growth, uteroplacental Doppler indices and maternal demographic characteristics: role in prediction of stillbirth
  99. Mid-pregnancy fetal biometry, uterine artery Doppler indices and maternal demographic characteristics: role in prediction of small-for-gestational-age birth
  100. Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis
  101. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial
  102. Re: Maternal obesity and excess of fetal growth in pre-eclampsia
  103. Accuracy of Predicting Fetal Loss in Twin Pregnancies Using Gestational Age-Dependent Weight Discordance Cut-Offs: Analysis of the STORK Multiple Pregnancy Cohort
  104. Neonatal Acid-Base Status in Term Fetuses: Mathematical Models Investigating Cerebroplacental Ratio and Birth Weight
  105. Perioperative management and outcomes of aortic surgery during pregnancy
  106. Poor neonatal acid-base status in term fetuses with low cerebroplacental ratio
  107. Ushering in a new dawn in obstetrics and gynecology: the industry of cell-free DNA testing
  108. Fetal growth reference ranges in twin pregnancy: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort
  109. Cardiovascular Implications in Preeclampsia
  110. Reversible De Novo Left Ventricular Trabeculations in Pregnant Women
  111. Crown–rump length discordance and adverse perinatal outcome in twin pregnancies: systematic review and meta‐analysis
  112. Association between reduced fetal movements at term and first trimester markers of impaired placental development
  113. Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia
  114. Neurodevelopmental outcome in isolated mild fetal ventriculomegaly: systematic review and meta-analysis
  115. Ultrasound estimation of birth weight in twin pregnancy: comparison of biometry algorithms in the STORK multiple pregnancy cohort
  116. Widening of the femoral proximal diaphysis-metaphysis angle in fetuses with achondroplasia
  117. Fetal and placental vascular tumors: persistent fetal hyperdynamic status predisposes to poorer long-term neurodevelopmental outcome
  118. Association between reduced fetal movements at term and abnormal uterine artery Doppler indices
  119. First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55 974 women
  120. Outcome of first-trimester fetal abdominal cysts: cohort study and review of the literature
  121. Changes in fetal Doppler indices as a marker of failure to reach growth potential at term
  122. Multiple pregnancy: Preface
  123. Prenatal prediction of need for ventriculoperitoneal shunt in open spina bifida
  124. Twin pregnancy chorionicity determination in a tertiary care setting
  125. Brain abnormalities and neurodevelopmental delay in congenital heart disease: systematic review and meta-analysis
  126. Second-trimester discordance and adverse perinatal outcome in twins: the STORK multiple pregnancy cohort
  127. Comment on “First trimester uterine artery Doppler velocimetry in the prediction of birth weight in a low-risk population”
  128. Biparietal diameter at 11 to 13 weeks' gestation in fetuses with holoprosencephaly
  129. Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial
  130. “Assisted” Reshaping of the Fetal Heart?
  131. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)
  132. Biparietal diameter at 11–13 weeks' gestation in fetuses with open spina bifida
  133. Value of adding second-trimester uterine artery Doppler to patient characteristics in identification of nulliparous women at increased risk for pre-eclampsia: an individual patient data meta-analysis
  134. Embryonic growth discordance and early fetal loss: the STORK multiple pregnancy cohort and systematic review
  135. Association between first‐trimester maternal serum pregnancy‐associated plasma protein‐A and obstetric complications
  136. Role of cerebroplacental ratio for fetal assessment in prolonged pregnancy
  137. Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis
  138. Crown-rump length discordance and adverse perinatal outcome in twins: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort
  139. Early fetal loss in monochorionic and dichorionic twin pregnancies: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort
  140. Weight discordance and perinatal mortality in twins: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort
  141. Does antenatal ultrasound labeling predict birth order in twin pregnancies?
  142. Trophoblast-Induced Changes in C-X-C Motif Chemokine 10 Expression Contribute to Vascular Smooth Muscle Cell Dedifferentiation During Spiral Artery Remodeling
  143. Comparison of Wavelet Transform and Time-Domain Analysis of Second Trimester Uterine Artery Doppler Waveforms in Screening for Pre-Eclampsia
  144. Cardiac structure and function in normal pregnancy
  145. Mid‐gestational maternal cardiovascular profile in preterm and term pre‐eclampsia: a prospective study
  146. Elective birth at 37 weeks of gestation versus standard care for women with an uncomplicated twin pregnancy at term: the Twins Timing of Birth Randomised Trial
  147. Counseling in fetal medicine: agenesis of the corpus callosum
  148. The diagnostic and therapeutic role of ultrasound in obstetrics
  149. Severe Myocardial Impairment and Chamber Dysfunction in Preterm Preeclampsia
  150. The effect of the contents of exomphalos and nuchal translucency at 11-14 weeks on the likelihood of associated chromosomal abnormality
  151. Prediction of Preeclampsia by Combining Serum Histidine-Rich Glycoprotein and Uterine Artery Doppler
  152. Neurodevelopmental delay in small babies at term: a systematic review
  153. Maternal Cardiovascular Impairment in Pregnancies Complicated by Severe Fetal Growth Restriction
  154. Impaired decidual natural killer cell regulation of vascular remodelling in early human pregnancies with high uterine artery resistance
  155. Mean, lowest, and highest pulsatility index of the uterine artery and adverse pregnancy outcome in twin pregnancies
  156. Corrections
  157. Relationship of first‐trimester uterine artery Doppler to late stillbirth
  158. Prospective risk of late stillbirth in monochorionic twins: a regional cohort study
  159. LEFT VENTRICULAR HYPERTRABECULATION IN AFRO-CARIBBEAN INDIVIDUALS: AN INHERITED CARDIOMYOPATHY OR A PHYSIOLOGICAL RESPONSE TO INCREASED CARDIAC PRELOAD
  160. A perfusion confusion?
  161. Prediction of selective fetal growth restriction and twin-to-twin transfusion syndrome in monochorionic twins
  162. Role of Second-Trimester Uterine Artery Doppler in Assessing Stillbirth Risk
  163. Screening for pre-eclampsia by using changes in uterine artery Doppler indices with advancing gestation
  164. Is first‐trimester crown–rump length associated with birthweight?
  165. Maternal cardiac function in preeclampsia
  166. Pregnancy Outcome of Monochorionic Twins: Does Amnionicity Matter?
  167. Antibiotic prophylaxis before amniocentesis
  168. The evidence base for miscarriage diagnosis: better late than never
  169. Preeclampsia Is Associated With Persistent Postpartum Cardiovascular Impairment
  170. Antenatal care for twin and triplet pregnancies: summary of NICE guidance
  171. Elevated glucocorticoid metabolism in placental tissue from first trimester pregnancies at increased risk of pre-eclampsia
  172. Systematic labeling of twin pregnancies on ultrasound
  173. Early prediction and prevention of pre-eclampsia
  174. Fetal hemoglobin and α1-microglobulin as first- and early second-trimester predictive biomarkers for preeclampsia
  175. First‐trimester ultrasound determination of chorionicity in twin pregnancy
  176. Uterine artery Doppler screening for pre-eclampsia: comparison of the lower, mean and higher first-trimester pulsatility indices
  177. Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies?
  178. Prevalence of maternal cardiac defects in women with high‐resistance uterine artery Doppler indices
  179. Prenatal diagnosis of non‐immune hydrops fetalis: what do we tell the parents?
  180. Maternal Cardiac Dysfunction and Remodeling in Women With Preeclampsia at Term
  181. Second‐trimester assessment of gestational age in twins: validation of singleton biometry charts
  182. Early pregnancy growth and pregnancy outcome in twin pregnancies
  183. Late termination of pregnancy and foetal reduction for foetal anomaly
  184. Early-Pregnancy Multiple Serum Markers and Second-Trimester Uterine Artery Doppler in Predicting Preeclampsia
  185. First-trimester ultrasound dating of twin pregnancy: are singleton charts reliable?
  186. Prenatal ultrasound in the prediction of bowel obstruction in infants with gastroschisis
  187. Prenatal findings and differential diagnosis of scimitar syndrome and pulmonary sequestration
  188. Sensitivity of higher, lower and mean second-trimester uterine artery Doppler resistance indices in screening for pre-eclampsia
  189. Giant placental chorioangioma: natural history and pregnancy outcome
  190. Cord entanglement and perinatal outcome in monoamniotic twin pregnancies
  191. The diagnostic and therapeutic role of ultrasound in obstetrics
  192. Guidelines for the management of postterm pregnancy
  193. Raised Maternal Serum Cystatin C: An Early Pregnancy Marker for Preeclampsia
  194. Relationship of intertwin crown-rump length discrepancy to chorionicity, fetal demise and birth-weight discordance
  195. First trimester PTX3 levels in women who subsequently develop preeclampsia and fetal growth restriction
  196. First‐trimester uterine artery Doppler indices in the prediction of small‐for‐gestational age pregnancy and intrauterine growth restriction
  197. Association of Uterine Artery Doppler Resistance Index and Birth Weight: Effect of Customized Birth Weight Standards
  198. First trimester uterine artery Doppler in women with previous pre‐eclampsia
  199. Congenital vascular malformations: A series of five prenatally diagnosed cases
  200. First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia
  201. Outcome of Fetuses With Antenatally Diagnosed Short Femur
  202. Predictors of necrotizing enterocolitis in preterm growth-restricted neonates
  203. Outcome of fetuses with antenatally diagnosed short femur
  204. First‐trimester uterine artery resistance and maternal serum concentration of asymmetric dimethylarginine
  205. Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin
  206. The prediction of intra-partum fetal compromise in prolonged pregnancy
  207. Ultrasound assessment of cervical length in prolonged pregnancy: prediction of spontaneous onset of labor and successful vaginal delivery
  208. Authors response to: Severe twin-twin transfusion syndrome: outcome after fetoscopic laser ablation of the placental vascular equator
  209. Computerized fetal heart rate analysis, Doppler ultrasound and biophysical profile score in the prediction of acid-base status of growth-restricted fetuses
  210. Outcome of antenatally diagnosed abdominal wall defects
  211. First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development
  212. Effect of heparin and fractionated heparin on trophoblast invasion
  213. Increased Apoptosis in First Trimester Extravillous Trophoblasts from Pregnancies at Higher Risk of Developing Preeclampsia
  214. Influence of parity on fetal mortality in prolonged pregnancy
  215. Severe twin-twin transfusion syndrome: outcome after fetoscopic laser ablation of the placental vascular equator
  216. Problem Based Obstetric Ultrasound
  217. MRI of the foetal brain
  218. Outcome of prenatally diagnosed agenesis of the corpus callosum
  219. Posterior fossa malformation in fetuses: a report of 56 further cases and a review of the literature
  220. The role of ultrasound in obstetrics
  221. Predictors of Neonatal Outcome in Early- Onset Placental Dysfunction
  222. First‐trimester uterine artery Doppler and spontaneous preterm delivery
  223. Maternal and neonatal outcome after failed ventouse delivery: Comparison of forceps versus cesarean section
  224. Prenatal diagnosis of segmental spinal dysgenesis
  225. Maternal cardiac function in early pregnancies with high uterine artery resistance
  226. Uterine artery Doppler velocimetry at 11–14 weeks in singleton pregnancies conceived by assisted reproductive technology
  227. Fetal surgical interventions
  228. Influence of parity on first trimester endovascular trophoblast invasion
  229. Do early pregnancy ultrasound measurements correlate with fetal nuchal translucency at 11–14 weeks?
  230. First-trimester nuchal translucency, nasal bones, and trisomy 21 in selected and unselected populations
  231. Effect of first-trimester serum from pregnant women with high-resistance uterine artery Doppler resistance on extravillous trophoblast invasion
  232. Effect of inter-twin delivery interval on neonatal haemoglobin concentration
  233. Effect of low dose heparin, unfractionated heparin and aspirin on trophoblast invasion
  234. Computerized fetal heart rate analysis (CCTG) for prediction of acidemia in fetal growth restriction (IUGR)
  235. Effect of serum from women with abnormal uterine artery Doppler resistance on extravillous trophoblast invasion in the first trimester
  236. Doppler and biophysical assessment in growth restricted fetuses: distribution of test results
  237. A newly described thoracic vascular malformation in fetuses with Down syndrome
  238. Neonatal outcome of antenatally diagnosed congenital cystic adenomatoid malformations
  239. First-Trimester Ductus Venosus, Nasal Bones, and Down Syndrome in a High-Risk Population
  240. The sensitivity of antenatal ultrasound for predicting renal tract surgery in early childhood
  241. Fetal congenital cardiac diverticulum with pericardial effusion: two cases with different presentations in the first trimester of pregnancy
  242. Natural history and outcome of prenatally diagnosed cystic hygroma
  243. Recent advances in the management of placenta previa
  244. Second‐trimester uterine artery Doppler and spontaneous preterm delivery
  245. Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies
  246. What prenatal diagnosis should be offered in multiple pregnancy?
  247. The Longitudinal Variation in Uterine Artery Blood Flow Pattern in Relation to Birth Weight
  248. Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices
  249. Viability in early-onset IUGR: is it time to reconsider intervention thresholds?
  250. Effect of parity on second‐trimester uterine artery Doppler flow velocity and waveforms
  251. Ultrasound-guided interstitial laser therapy for the treatment of placental chorioangioma
  252. Pre-natal diagnosis: structural anomalies
  253. First‐trimester uterine artery blood flow and birth weight
  254. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia
  255. Association between increased nuchal translucency and second trimester cardiac echogenic foci*1
  256. The role of oxytocin in parturition
  257. A newly recognized autosomal recessive syndrome with abnormal vertebral ossification, rib abnormalities, and nephrogenic rests
  258. Nuchal translucency thickness measurement: repeatability using a virtual ultrasound scanner
  259. Improving the effectiveness of routine prenatal screening for major congenital heart defects
  260. Prospective risk of stillbirth in multiple-gestation pregnancies: a population-based analysis
  261. Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening
  262. Comparison of feticide carried out by cordocentesis versus cardiac puncture
  263. Outcome of antenatally diagnosed talipes equinovarus in an unselected obstetric population
  264. Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus
  265. Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus
  266. Sensitivity and accuracy of routine antenatal ultrasound screening for isolated facial clefts
  267. Routine ultrasound for the prenatal diagnosis of congenital diaphragmatic hernia: the ‘isms’
  268. Fetal medicine: a liquid frontier
  269. Uterine artery resistance and anxiety in the second trimester of pregnancy
  270. The human ductus venosus between 13 and 17 weeks of gestation: histological and morphometric studies
  271. Reproducibility and repeatability of transabdominal uterine artery Doppler velocimetry between 10 and 14 weeks of gestation
  272. The anatomy of the umbilical, portal and hepatic venous systems in the human fetus at 14-19 weeks of gestation
  273. Significance of chromosome 22q11 analysis after detection of an increased first-trimester nuchal translucency
  274. The role of ultrasound in the expectant management of early pregnancy loss
  275. Fetal anemia as a consequence of hemorrhage into an ovarian cyst
  276. Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler
  277. Intraobserver and interobserver variability of transabdominal Doppler velocimetry measurements of the fetal ductus venosus between 10 and 14 weeks of gestation
  278. Role of ultrasound in obstetrics
  279. Natural history of fetal hydronephrosis diagnosed on mid-trimester ultrasound
  280. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects
  281. Increased nuchal translucency and normal karyotype: coping with uncertainty
  282. Antenatal diagnosis of fetal intra‐abdominal umbilical vein dilatation
  283. Sono-endoscopic delineation of the placental vascular equator prior to selective fetoscopic laser ablation in twin-to-twin transfusion syndrome
  284. Twin-to-twin transfusion syndrome - debates on the etiology, natural history and management
  285. Coping with winter bed crises
  286. Effectiveness of prenatal chromosomal analysis using multicolour fluorescent in situ hybridisation
  287. First trimester screening for fetal abnormalities
  288. First trimester nuchal translucency: effective routine screening for Down's syndrome.
  289. Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population.
  290. First‐trimester nuchal translucency and maternal serum biochemical screening for Down's syndrome: a happy union?
  291. Influence of ethnic origin on nuchal translucency screening for Down's syndrome
  292. TRANSFER OF NUCLEATED MATERNAL CELLS INTO FETAL CIRCULATION DURING THE SECOND TRIMESTER OF PREGNANCY
  293. A nude mouse xenograft model to investigate slow cycling edidermal stem cells
  294. Relationship between fetal nuchal translucency thickness and second trimester maternal serum biochemistry
  295. Racial equity of screening for trisomy 21: comparison of nuchal translucency and maternal serum biochemistry
  296. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome
  297. Nuchal translucency: a marker for the antenatal diagnosis of aortic coarctation
  298. Maternal platelet size as a marker for fetal trisomies 18 and 13
  299. Neutrophil and monocyte β2-integrin expression in trisomic fetuses
  300. Blood transferrin receptor expression in chromosomally abnormal fetuses
  301. Neutrophil and monocyte β2-integrin expression in maternal and fetal blood
  302. Labor: An immunologically beneficial process for the neonate
  303. Fetal immunodeficiency: A consequence of placental insufficiency
  304. Platelet size and glycoprotein Ib and IIIa expression in normal fetal and maternal blood
  305. Predicting the severity of rhesus alloimmunization: monocyte-mediated chemiluminescence versus maternal anti-D antibody estimation
  306. Subpopulations of CD34‐positive haemopoietic progenitors in fetal blood
  307. Umbilical cord blood erythroblast count as an index of intrauterine hypoxia.
  308. Abnormal immunological development in fetuses with trisomy 18
  309. Fetal Blood Mononuclear Cell Division in Normal and Pathological Pregnancies
  310. Maternal Peripheral Blood Lymphocyte Subpopulations in Normal and Pathological Pregnancies
  311. Fetal plasma erythropoietin concentration in red blood cell‐isoimmunized pregnancies
  312. Fetal plasma interferon gamma concentration in normal pregnancy
  313. Abnormal fetal immunological development in Down's syndrome
  314. Fetal B Lymphocyte Subpopulations in Normal Pregnancies
  315. Management of the third stage of labour in women at low risk of postpartum haemorrhage
  316. Fetal plasma erythropoietin concentration in red blood cell-isoimmunized pregnancies
  317. Erythroblastosis in birth asphyxia
  318. Fetal and Maternal Erythropoietin Levels in Normal Pregnancy
  319. Cordocentesis in the investigation of fetal erythropoiesis
  320. Erythroblastosis and reticulocytosis in anemic fetuses
  321. Antenatal care for women with pre-existing medical, obstetric or mental health conditions